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Concepts of Nanoparticle Dose
Metric and Response Metric
Wittmaack (2007) did not agree with our
suggestion (Oberdörster et al. 2005) that
particle surface area is a more appropriate
dose metric than particle mass or particle
number when evaluating dose–response
relationships of nanoparticle-induced pul-
monary inflammation. According to his
understanding of nanotoxicology and
based on his calculations, he found particle
number to work best as a dose metric.
Throughout our review we pointed out that
the surface area concept should be consid-
ered in the context of nanoparticle surface
properties such as chemistry, charge, coat-
ing, crystallinity, porosity, and reactivity.
For example, nano-titanium dioxide (TiO2)
or nano-copper particles, very distinct from
one another, will predictively create separate
well-fitting surface area dose–response
relationships. Yes, particle number is of
importance as well, as we indicated in our
review, but not as a direct dose metric. 
We would like to address some of the
issues Wittmaack (2007) raised in his article.
First, Wittmaack suggested that when
expressing a pulmonary inflammatory
response, a response metric is better done
using the ratio of lavaged neutrophils
(PMN; polymorphonuclear leukocytes) to
macrophages instead of using the fraction
of PMNs. Because the purpose of our
review (Oberdörster et al. 2005) was not
to describe these responses in mathemati-
cal terms (whether threshold, linear, or
nonlinear) but rather to illustrate that
dose–response relationships on a mass
basis—but not on a surface area basis—are
very different, the choice of the response
metric is irrelevant. To demonstrate this, we
present our data again (Figure 1), expressed
as absolute numbers of elicited PMNs and
as PMN/macrophage ratios as a function of
administered mass (Figure 1A,B), number
(Figure 1C,D), or surface area (Figure 1E,F)
of fine and ultrafine (nanosized) TiO2. The
dose–response relationships based on mass
and surface area are essentially the same as
those shown in our review (Oberdörster
et al. 2005) using the percentage of elicited
neutrophils. 
Second, regarding the issue of particle
number being the best dose metric, the par-
ticle number dose–response relationships
(Figure 1B) are several orders of magnitude
apart for fine and ultrafine TiO2, whereas the
surface area plot (Figure 1C) shows a good fit
for the combined particle sizes. The reviewers
of Wittmaack’s article (2007) apparently
overlooked this flaw in his argument. 
Finally, Wittmaack (2007) calculated
that the surface area for ultrafine TiO2
should be 77 m2/g and not 50 m2/g, as we
reported (Oberdörster et al. 2005). He
derived his value on the basis of the specific
density of TiO2 (anatase) and a spherical pri-
mary particle size of 20 nm. BET surface
area for this TiO2 (Degussa P25) has been
measured independently by a number of
investigators, including our group (Jwo et al.
2005; Long et al. 2006; Wahl et al. 2005),
and ranges between 48 and 55 m2/g. There
is no reason to mathematically manipulate
this number to a value that is completely at
odds with actual measurements. In contrast
to the well-established surface area, the aver-
age primary particle size of TiO2 has not
been firmly established, with values of
20–30 nm. Indeed, a size of 30 nm (calcu-
lated surface area, 51.2 m2/g) conforms best
to the measured BET surface. Thus, we
added particle number dose–response data
for 30 nm TiO2 to Figure 1C and 1D; the
order of magnitude difference of the dose
response between fine and ultrafine particles
is obvious, regardless of whether the ultrafines
are considered to be 20 or 30 nm in size.
We have concluded that of the three
dose metrics discussed, particle number is
the worst to describe nanoparticle-induced
pulmonary inflammatory effects.
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Inflammatory Response to
TiO2 and Carbonaceous
Particles Scales Best with BET
Surface Area
In an attempt to identify the proper dose
metric for particle toxicity, Wittmaack
(2007) reanalyzed our dose–response data
(Stoeger et al. 2006) and that of Oberdörster
et al. (2005) on acute lung inflammation in
rodents after instillation of various particle
types. Out of particle BET surface area
(SBET), particle number, joint length, and
“geometric” surface area, Wittmaack con-
cluded that particle number tends “to work
best” as dose metric. We disagree with his
conclusion.
First, we wonder why Wittmaack
(2007) used our data but ignored the data
of Oberdörster et al. (2005) for the identifi-
cation of the best dose metric. Figure 1
shows our dose–response data (in mice) for
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Figure 1. Inflammatory cell response in lung lavage 24 hr after intratracheal instillation of fine (~ 250 nm) and
ultrafine (20–30 nm) TiO2 expressed by different dose metrics [particle mass (A,B), number (C,D), and surface
area (E,F)] and different response metrics [number of PMNs (A,C,E) and PMN/macrophage ratio (B,D,F)].six different types of ultrafine carbonaceous
particles (10–50 nm) and the data of
Oberdörster et al. (2005) for fine (~ 250 nm)
and ultrafine (~ 20 nm) TiO2 particles; we
present the data for rats, which was reana-
lyzed by Wittmaack, and also the mouse data
from Oberdörster et al. (2005). In Figure 1
the inflammatory response after 24 hr is
expressed as the ratio of the polymorpho-
nuclear leukocytes (PMNs) to lavaged cells,
and the instilled dose is normalized to lung
weight, because this facilitates interspecies
comparison (Oberdörster et al. 2005). As
suggested by Wittmaack (2007), we limit
our discussion to the linear response regime
[analogous to his Figure 3 (Wittmaack
2007)]. For this data set, the linear correla-
tion coefficient R2 is 0.46, 0.51, 0.67, and
0.72 for particle number, joint length, “geo-
metric” surface area, and SBET, respectively.
Particularly, the response to the fine parti-
cles, as represented by the red fit line (almost
identical to the y-axis in Figure 1A), is not
adequately described by particle number
(Figure 1A), whereas SBET works well for all
particle sizes (Figure 1B). Although we do
not suggest SBET as a “universal” dose metric
(chemistry, charge, etc., are also relevant),
we conclude that for the dose metric exam-
ined here, SBET is the most relevant dose
parameter. Wittmaack’s preference for parti-
cle number appears to be the result of an
unsubstantiated restriction of his analysis to
our data, which is dominated by particles in
a relatively narrow size regime between
about 10 and 25 nm.
Second, all investigated dose parameters
(except SBET) depend on accurate determi-
nation of the mean particle diameter, <d>,
requiring tedious and potentially uncertain
single particle analysis. Wittmaack (2007)
acknowledged potentially large errors in
<d> for particles below about 20 nm [i.e.,
for four out of our six (carbonaceous) parti-
cle types]. Being aware of these limitations,
we intentionally reported only a range of
observed particle diameters (not <d>) in our
article (Stoeger et al. 2006). Unfortunately,
Wittmaack did not discuss his conclusions
in light of these methodologic limitations.
Especially for the smallest particle type
(here spark-generated carbon particles with
<d> = 9.8 nm), preferential particle selec-
tion is likely to result in an overestimation
of <d>. Assuming a 25% sizing error, this
yields a systematic error of + 100% in parti-
cle number (~ <d>–3), which shifts these
data points far away from the linear fit line
(see error bars in Figure 1A). In contrast,
SBET requires only a single measurement on
an aliquot of the administered particles;
that is, it is not adversely affected by prob-
lems associated with single particle analysis,
and it adequately accounts for potentially
important particle characteristics such as
particle morphology and surface porosity. 
In summary, we do not agree with the
dose–response interpretation of our data by
Wittmaack (2007). We conclude that SBET
(and not particle number) is the best dose
parameter, accounting for 72% (R2 = 0.72)
of the observed inflammatory response for
both data sets spanning a size range of
10–250 nm.
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Dose and Response Metrics in
Nanotoxicology: Wittmaack
Responds to Oberdoerster
et al. and Stoeger et al.
In their letters, Oberdörster et al. and
Stoeger et al. present some comments on a
few out of many issues that I addressed in
my reanalysis of literature data on lung
inflammatory response to nanoparticle
exposure (Wittmaack 2007). I appreciate
the opportunity to strengthen and expand
my arguments. 
I argue that results of nanoparticle toxi-
cology studies should not be interpreted on
the basis of the reasoning that the number
of surface atoms, relative to all atoms in a
(spherical) particle, increases as the inverse
of the diameter, D (Oberdörster et al.
2005). If the toxicity of an insoluble particle
scales with the number of surface atoms, it is
the surface area (A) that counts, not its ratio
to the mass (M). Figure 1 shows the size
dependence of the specific surface area (S =
A/M = 6/ρD) for TiO2 particles [mass den-
sity, ρ(anatase) = 3.9 g/cm3]. Also presented
is an example for the cumulative surface area
(ΣAae) calculated from the mean number
concentration of an ambient aerosol
(Wittmaack 2002), including extrapolated
data for D < 10 nm. ΣAae decreases rapidly
with decreasing D, notably for D < 100 nm.
In contrast, Sae = ΣAae/ΣMae = ΣAae/ρΣVae
(ρ = 1.5 g/cm3) increases as 1/D, for
D < 200 nm, where V is the particle volume.
If toxicity is assessed by reference to Sae
rather than to Aae, the danger of exposure to
nanoparticles (e.g., for D = 30 nm), com-
pared to fine particles (D = 1 µm), is overes-
timated by a factor of 1,130. By taking the
ratio A/M, we compare apples (the surface
area of insoluble particles) and oranges (the
mass of soluble particles).
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Figure 1. Acute pulmonary inflammatory response
(PMNs) to TiO2 [Oberdörster et al. 2005; Figure 4
and Figure S-2 (Supplemental Material available
online at http://ehp.niehs.nih.gov/members/2005/
7339/supplemental.pdf)] and carbonaceous parti-
cles (Stoeger et al. 2006; Figure 1) in rats and mice,
















































































Figure 1. Particle-size dependence of the A/M
and the ΣAae. The straight line relates to TiO2
particles, the open and solid circles indicate
ambient aerosol particles, and the crosses indi-
cate two BET data. According to Oberdoerster
et al.’s letter, the so-called 20-nm TiO2 particles
may well have been 30 nm in size. This type of reasoning in terms of Sae
(Oberdörster et al. 2005) has been used
often (Kreyling et al. 2006; Nel et al. 2006 );
Gwinn and Vallyathan (2006) even charac-
terized ultrafine particles (UFPs; i.e., parti-
cles with D ≤ 100 nm) as “UFPs with larger
surface area.”
In their Figure 1, Oberdörster et al.
(2005) reproduced some of their own data
in two ways: as the number (nPMN) of
lavaged polymorphonuclear leukocytes
(PMNs) and as the ratio (rP,m) of nPMN to
the number (nma) of macrophages (rP,m
= nPMN/nma). To demonstrate that the par-
ticle number is not an appropriate dose
metric in the special case of TiO2, the data
could have been presented in a single graph.
I found that particle number is a suitable
dose metric for differently prepared carbon
nanoparticles (Wittmaack 2007). In their
letter, Oberdörster et al. use the comparison
between nPMN and rP,m to argue that “the
choice of the response metric is irrelevant.”
Data analysis shows that in their study nma
was essentially constant (10.9 ± 0.5) × 106.
Hence, if nPMN is divided by nma ≅ con-
stant, on appropriate scales, the ratio rP,m
looks essentially the same as the nPMN.
Clearly, this result is not proof of the cited
assertion.
To explore this issue further, Figure 2
shows a direct comparison of rP,m with the
corresponding fractions fP,m = nPMN /(nPMN
+nma) = rP,m /(1+rP,m) for the 250-nm TiO2
data, according to Oberdörster et al.’s letter.
The solid line in Figure 2, derived by linear
regression analysis of the rP,m data, agrees
well with previous results (Wittmaack
2007). Further evaluation provided the clue
to the issue in question. By converting the
rP,m regression data to fractions fP,m, I
obtained the curve (dashed line), which is
clearly nonlinear. Hence, using the fP,m
approach, Oberdörster (2000) converted an
existing linear dose–response relationship
(for nPMN or rP,m) artificially to a depen-
dence that feigns the onset of saturation
effects. Therefore, the choice of the response
metric is not irrelevant.
Preparing Figure 1 of their letter,
Stoeger et al. changed from the right
(nPMN) (Stoeger et al. 2006) to the wrong
(fP,m) response metric. For mice exposed to
different types of carbon particles except for
those with high carbon content (SootH), I
derived from their Figure 1B rather high
mean lung masses of 0.287 ± 0.047 g, and
even higher values (0.469 ± 0.028 g) for the
SootH-exposed animals. The ratio of these
two masses (0.61) is the same as that of the
ratio SBET(SootH)/SBET (SootL). This
means that their data were erroneously per-
muted. Also, the fP,m carbon particle data
are poorly correlated with the original
nPMN data (Stoeger et al. 2006) because the
numbers of “lavaged cells,” presumably
macrophages, derived from the nPMN and
fP,m data, differ vastly (i.e., between about
2 × 105 and 3 × 106. Hence, either the fP,m
data in the letter of Stoeger et al. were mis-
calculated, or nma exhibited a biologically
unreasonable spread. Furthermore, they
include 15 response data for carbon in their
letter, but the linear dose–response region
contains only 13 (Wittmaack 2007).
In their effort to show that the surface
area constitutes a proper all-particle dose
metric, Stoeger et al. (2006) discredited
their own transmission electron microscopy
analysis. Their argument is irrelevant
because the spark-generated particles con-
tributed only one data point to a total of
13. Finally, Stoeger et al. do not accept one
of the most important points of my article:
Carbon particles of different origin exhibit
large differences in surface toxicity and,
therefore, they cannot be used to identify
the best dose metric. Moreover, combining
TiO2 and carbon data in one graph is not
an appropriate comparison.
The author declares he has no competing finan-
cial interests.
Klaus Wittmaack
GSF–National Research Center for
Environment and Health
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Lippmann et al. (2006) attempted to iden-
tify subtle deleterious effects in fine airborne
particulate matter (FPM), which is laudable.
Nevertheless, the authors’ claim (Lippmann
et al. 2006) that on 14 of 103 days studied
in the fall of 2004, concentrated air pollu-
tants (CAPs) at Tuxedo, New York [near
New York City (NYC)], contained “greatly
elevated concentrations of nickel attribut-
able to the Ni smelter at Sudbury, Ontario”
is unsubstantiated. The Ni concentrations to
which they referred (174 ng/m3) on these
14 days were concentrated 10-fold from
ambient air. In other words, the Ni in ambi-
ent air at Tuxedo was actually only
17.4 ng/m3, the same as NYC (19 ng/m3).
Lippmann et al. (2006) assigned the “ele-
vated” Ni to Inco’s 381 m stack in Sudbury
based on back trajectory analyses. The
authors failed to account for vertical compo-
nents of air parcel movement; also, by sin-
gling out one specific trajectory from the
“NW wind” days, they implied much more
accuracy to the back trajectories than is justi-
fied. Because meteorological data are avail-
able at 3-hr intervals, three back trajectories
could be developed for each daily exposure
period. Such back trajectories using the
internet-based HYSPLIT model (National
Oceanic and Atmospheric Administration
2006) indicate that for the 14 NW wind
days, elevated Ni in CAPs on those days was
more likely due to sources other than the
Sudbury stack > 800 km distant. Further-
more, Inco’s stack emissions are characteris-
tic and distinct from the CAPs composition
reported by Lippmann et al. (2006).
Concentrations of aluminum, chromium,
and iron are all 100-fold less than the con-
centration of Ni in Inco’s emissions, whereas
in CAPs on the NW wind days, the ratios of
Cr:Ni and Fe:Ni, as well as those of Al:Ni
and V:Ni, are similar to those of New Jersey
air (Reinfelder et al. 2004). The Ni in ambi-
ent air at Tuxedo, even on the 14 NW wind
days, could be easily assigned to sources sur-
rounding NYC. Given that Tuxedo is near
NYC, it should be no surprise that local
sources could be large contributors to Ni in
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Figure 2. Response of rats to the instillation of
250 nm TiO2 particles shown as the rP,m as
reported by Oberdörster et al. in their letter, and
the derived fP,m corresponds to the linear fit
through the rP,m data.ambient FPM in Tuxedo. Although the
atmospheric Ni emissions from the Sudbury
stack can be transboundary and have been
significant historically, the incremental con-
tribution of Ni from Sudbury to ambient air
at Tuxedo in 2004 would have been dwarfed
relative to local sources. Significant reduc-
tions in emissions have been made at Inco’s
Sudbury operations, and air emissions from
the Inco stack will diminish further as new
pollution control measures are implemented.
Lippmann et al. (2006) presented two
lines of evidence that Ni is the major cause
of cardiovascular effects of FPM. First, expo-
sures of ApoE–/– mice to CAPs led them to
conclude that unusually high heart rate
(HR) occurred in response to elevated Ni on
the NW wind days. Although the largest
sustained apparent difference in HR
occurred through most of December, only
three NW wind days occurred in that
month. Other changes in HR and heart rate
variability (HRV) are either due to changes
in control animals or occurred when there
were no elevated Ni concentrations [see
Figure 4 of Lippmann et al. (2006)]. There
appears to be an error in the key of
Lippmann et al.’s Figure 4 compared with
the original manuscript published online:
the solid lines now denote filtered air (con-
trol) instead of CAPs, and the dashed line
indicates CAPs instead of control data.
Given that the authors referred to the ele-
vated HR in exposed mice, the key in the
print version must be incorrect.
Considering that 2-year inhalation expo-
sures of rodents to nickel sulfate at levels 600
times higher than those used by Lippmann
et al. (2006) were without effect on mortal-
ity, the relevance of the “subtle” changes in
HR and HRV requires further thought.
Second, the authors “wondered if Ni may
have been responsible for the notably high
daily mortality” in NYC. Although it is true
that NYC has a cardiovascular and respira-
tory (CVR) mortality coefficient that is
above the national average, 34 of the
90 National Mortality and Morbidity Air
Pollution Study (NMMAPS) cities have
CVR mortality coefficients greater than
those of NYC. Furthermore, there is no
statistical relationship between NMMAPS
CVR mortality rates and Ni emission rates
(U.S. Environmental Protection Agency
2002).
The conclusions of Lippmann et al.
(2006) contrast with the recent assessments
of the Agency for Toxic Substances and
Disease Registry (ATSDR 2005) and the
European Union (European Chemicals
Bureau 2005) that did not identify human
cardiovascular risk factors for Ni. Historical
monitoring within the Ni industry identified
the link between high occupational exposure
of certain Ni species and respiratory cancer,
but no such cardiovascular risk factors have
been identified after decades of occupational
health monitoring.
Further research to evaluate the impacts
of the constituents of FPM on cardiovascular
health is justified and should continue.
Nevertheless, researchers with appropriate
expertise work should cooperatively in studies
such as these. In this instance, Lippmann
et al. (2006) would have benefitted greatly
from the inclusion of atmospheric scientists
on their research team.
The author is employeed by CVRD Inco
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Cardiovascular Effects of Nickel:
Lippmann et al. Respond
It is readily understandable that Dutton of
the International Nickel Company (INCO)
would like to separate the nickel emissions
from the 381-m INCO smelter stack from
the highly statistically significant Ni-associ-
ated effects on heart rate and heart rate vari-
ability that we observed on 14 of 103
consecutive weekdays of exposure in our
laboratory (located within the Sterling
Forest State Park) in a mouse model of
atherosclerosis (Lippmann et al. 2006).
Indeed, it is possible that some closer source
of Ni could have been responsible for the
effects. However, as we noted in our article,
the back trajectories on the 14 days with
unusually elevated Ni concentrations did
not pass over any known industrial sources
or large urban areas, but did pass over or
near the distant point source of Ni at the
INCO smelter in Sudbury, Ontario,
Canada. It is also noteworthy that the
14 back trajectories, illustrated in Figure 2
of our article (Lippmann et al. 2006),
approached Sterling Forest from a variety of
directions, ranging from the NW to the
NNE, making it highly unlikely that that
their metals compositions were influenced
by a significant source within a 100-mi
radius. Furthermore, both the directions of
the incoming winds and the combination of
unusually high Ni and lower than normal
vanadium on those 14 days, as compared
with the other 89 days of observation,
seemed to preclude the major sources of Ni
being the Port of New York, the New York
City metropolitan area, or other coastal
regions where residual oil is used to generate
heat and electrical power. It is well known
that residual oil combustion effluents are
high in both Ni and V.
We commend Dutton on identifying a
mislabeled key in Figure 4 of our article
(Lippmann et al. 2006) that occurred during
the preparation of the print version. As he
noted, the original manuscript published
online was correctly labeled. (See the
Erratum on p. A294.)
Dutton provided no supporting refer-
ence for his comment that “2-year inhala-
tion exposures of rodents to nickel sulfate at
levels 600 times higher than those used by
Lippmann et al. (2006) were without effect
on mortality ….” Based on the 600× con-
centration difference, we assume he was
referring to a National Toxicology Program
(NTP) report (NTP 1996). It should be
noted that healthy B6C3F1 mice were
exposed in this study, and that healthy B6
mice had much greater survival times than
seven other inbred mice strains when
exposed to nickel sulfate by Prows et al.
(2003).
Dutton also states that “there is no sta-
tistical relationship between NMMAPS
[National Mortality and Morbidity Air
Pollution Study] CVR [cardiovascular risk]
mortality rates and Ni emission rates.”
Again, no reference was cited. Even if his
statement was supported by a negative
study, it relates to emissions and not con-
centrations. In our article (Lippmann et al.
2006), we showed that the annual average
PM10 (particulate matter < 10 µm in aero-
dynamic diameter) NMMAPS mortality
coefficients for 60 NMMAPS cities were
significantly associated with annual average
ambient Ni and V concentrations in those
same cities.
Finally, we take exception to Dutton’s
comment that implies that we lack suffi-
cient expertise in atmospheric science. The
only issue in our article that relates to
atmospheric science is our use of HYSPLIT
back trajectories, and we fail to see how we
misused them.
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ERRATUM
In Figure 4 of Lippmann et al.
[Environ Health Perspect 114:1662–1669
(2006)], the key was correct in the origi-
nal manuscript published online but was
incorrect in the final version. The dashed
lines should indicate filtered air, and the
solid lines should denote CAPS. The
corrected figure appears below.













































Figure 4. Daily group averaged HR (A) and
HRV (logSDNN) (B) in mice exposed to CAPs
or filtered air.